State AIDS programs struggle as joblessness increases demand

NewsGuard 100/100 Score

NPR: Growing joblessness and shrinking state and federal budgets have exacerbated the financial burden on the government that provides prescription drug treatment to people with HIV/AIDS. "Now, many people with HIV are losing jobs, along with insurance, or discovering that they are infected at a time when the AIDS Drug Assistance Program — ADAP — they depend on is being overwhelmed by demands being made on it. Federal and state budgets aren't meeting the challenge." As of July 1, Georgia had to begin adding new applicants to its AIDS drug program to a waitlist. Last month, Florida did the same, and now carries more than 500 people on its waitlist. A Florida official said, "Over the last several months in the latter part of this recession, we have been averaging over 350 patients a month coming forward for assistance" (Wilson, 7/7).

Bay Area Reporter, a San Francisco weekly: "Officially, 1,924 people are now on ADAP waiting lists in 11 states, federal ADAP administrator Deborah Parham Hopson told the Presidential Advisory Committee on HIV/AIDS at its June 29 meeting. That is about 1 percent of the people served by the program. Three years ago there were no ADAP waiting lists." But, other HIV/AIDS patients are also no longer getting help they once received. According to the Bay Area Reporter, Ohio lowered income eligibility last month and stopped paying for medication for 320 people.  Louisiana stopped enrolling new ADAP beneficiaries in June, but created no waiting list. And, other states have curbed benefits by reducing the number or type of drugs covered, or tightened income and employment requirements to make ends meet (Roehr, 7/8).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers receive NIH grant to help develop gene therapy for HIV